|
|
|
| This article has been cited by | | 1 | Immune checkpoint inhibitor-related cholangiopathy: Novel clinicopathological description of a multi-centre cohort | | | Philip Berry,Sreelakshmi Kotha,Yoh Zen,Sophie Papa,Tareq El Menabawey,George Webster,Deepak Joshi,Michael Heneghan | | Liver International.2023;43(1)147 | | [DOI] | | | 2 | Pembrolizumab | | | Philip Berry,Sreelakshmi Kotha,Yoh Zen,Sophie Papa,Tareq El Menabawey,George Webster,Deepak Joshi,Michael Heneghan | | Reactions Weekly.2021;1852(1)356 | | [DOI] | |
|
